Skip to main content

Table 1 Clinicopathologic characteristics of patients undergoing liver resection for colorectal cancer hepatic metastasis

From: Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy

Characteristics

Oncologic scores ≥ 2

n = 266 (%)

Oncologic scores < 2

n = 210 (%)

p value

Age (years), median (range)

60 (29–88)

61 (29–88)

0.503

Gender

  

0.317

 Male

176 (66.2)

148 (70.5)

 

 Female

90 (33.8)

62 (29.5)

 

Primary tumor location

  

0.776

 Right colon

43 (16.2)

36 (17.1)

 

 Left colon

223 (83.8)

174 (82.9)

 

Metastatic types

  

< 0.0001

 Synchronous

225 (84.6)

46 (21.9)

 

 Metachronous

41 (15.4)

164 (78.1)

 

Serum CEA

  

< 0.0001

 < 60 ng/mL

201 (75.6)

202 (96.2)

 

 ≥ 60 ng/mL

65 (24.4)

8 (3.8)

 

Maximum tumor size

  

< 0.0001

 < 5 cm

178 (66.9)

200 (95.2)

 

 ≥ 5 cm

88 (33.1)

10 (4.8)

 

Tumor number

  

< 0.0001

 < 5 nodules

226 (85.0)

207 (98.6)

 

 ≥ 5 nodules

40 (15.0)

3 (1.4)

 

Primary lymph node

  

< 0.0001

 Positive

228 (85.7)

93 (44.3)

 

 Negative

38 (14.3)

117 (55.7)

 

CRC recurrence after liver resection.

  

0.004

 Yes

182 (68.4)

117 (55.7)

 

 No

84 (31.6)

93 (44.3)

 

Patient’s final status

  

0.026

 Alive and CRC-free

75 (28.2)

89 (42.4)

 

 Alive with recurrent CRC

77 (28.9)

47 (22.4)

 

 Dead of CRC

105 (39.5)

70 (33.3)

 

 Dead of other causes

6 (2.3)

3 (1.4)

 

 Surgical mortality

3 (1.1)

1 (0.5)

 
  1. CRC colorectal cancer